Possible articles FOM3 exam 13/12:

 https://www.nejm.org/doi/full/10.1056/NEJMoa2210027?
query=featured_home Chronic hepatitis B infection: new drug <3
 https://www.nejm.org/doi/full/10.1056/NEJMoa2210645 Triglyceride
Lowering with Pemafibrate to Reduce Cardiovascular Risk
 https://www.nejm.org/doi/full/10.1056/NEJMoa2205416 Fazirsiran for Liver
Disease Associated with Alpha1-Antitrypsin Deficiency
 https://www.nejm.org/doi/full/10.1056/NEJMoa2208375 Effect of
Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
 https://www.nejm.org/doi/full/10.1056/NEJMoa2203690 Trastuzumab
Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
 https://www.nejm.org/doi/full/10.1056/NEJMoa2202809 Pembrolizumab plus
Chemotherapy in Advanced Triple-Negative Breast Cancer
 https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00632-
5/fulltext#section-3d6acba1-acea-4be2-8dc9-b7e14e5b6583 Fluorouracil and
dose-dense adjuvant chemotherapy in patients with early-stage breast cancer
(GIM2): end-of-study results from a randomised, phase 3 trial
 https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00303-
X/fulltext Etrolizumab as induction and maintenance therapy in patients with
moderately to severely active Crohn's disease (BERGAMOT): a randomised,
placebo-controlled, double-blind, phase 3 trial
 https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00317-
X/fulltext Global prevalence of non-alcoholic fatty liver disease and non-
alcoholic steatohepatitis in the overweight and obese population: a systematic
review and meta-analysis
 https://www.nature.com/articles/s41591-022-02068-8 Circulating tumor DNA
as a novel prognostic indicator
 Microbiome-derived ethanol in nonalcoholic fatty liver disease
https://www.nature.com/articles/s41591-022-02016-6
 Effects of elevated systolic blood pressure on ischemic heart disease: a Burden
of Proof study https://www.nature.com/articles/s41591-022-01974-1
 Screening for idiopathic pulmonary fibrosis using comorbidity signatures in
electronic health records https://www.nature.com/articles/s41591-022-02010-y
Topics that come to my mind:
- Barrett’s esophagus
- Lung cancer
- Psoriasis
- Emphysema
- Asthma
- Colorectal cancer
- Hepatocellular carcinoma
- Breast cancer
FREE ARTICLES:
 https://pubmed.ncbi.nlm.nih.gov/36113532/ HPV vaccine
 Regular exercise improves asthma control in adults: A randomized controlled trial
https://pubmed.ncbi.nlm.nih.gov/31427628/ un po’ vecchio 3 anni
 Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients
With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial
https://pubmed.ncbi.nlm.nih.gov/35368058/
 Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in
Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT
Randomized Clinical Trial.
 Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a
multicentre, double-blind, randomised, phase 3 trial.n https://pubmed.ncbi.nlm.nih.gov/34656227/
 First-line nivolumab plus ipilimumab versus chemotherapy in patients with
unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.
 Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine
in People Aged 75 Years or Older.
 Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-
controlled cases series and matched cohort study.

ARTICOLI DA VEDERE:

DOI: 10.1056/NEJMoa2210639 RAAS

DOI: 10.1056/NEJMoa2204233 CKD

DOI: 10.1056/NEJMra1800868 FROSTBITE

DOI: 10.1056/NEJMoa2204233 CKD

DOI: 10.1056/NEJMra2201153 AKD and CKD review

DOI: 10.1056/NEJMoa2205416 A1AT deficiency

DOI: 10.1056/NEJMoa2201737 IPF

DOI: 10.1056/NEJMra2104090 AKI review

ATHEROSCLEROSIS: RECENT DEVELOPMENTS